Sharon Mates Intra Cellular Therapies, Inc. (ITCI) insider trading activity

Sharon Mates is Chairman and CEO of Intra-Cellular Therapies, Inc.. Currently has a direct ownership of 0 shares of ITCI, which is worth approximately $0. The most recent transaction as insider was on Apr 02, 2025, when has been sold 945,235 shares (Common Stock) at a price of $132.0 per share, resulting in proceeds of $124,771,020. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Sharon Mates Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 02 2025	SELL Sale (or disposition) back to the issuer	$124,771,020 $132.0 p/Share	945,235 Reduced 100.0%	0 Common Stock
Mar 26 2025	SELL Bona fide gift	-	190,000 Reduced 16.74%	945,235 Common Stock
Mar 10 2025	SELL Payment of exercise price or tax liability	$1,329,329 $131.24 p/Share	10,129 Reduced 0.88%	1,135,235 Common Stock
Mar 10 2025	BUY Exercise of conversion of derivative security	-	20,566 Added 1.76%	1,145,364 Common Stock
Mar 06 2025	SELL Payment of exercise price or tax liability	$2,603,859 $131.19 p/Share	19,848 Reduced 1.73%	1,124,798 Common Stock
Mar 06 2025	BUY Exercise of conversion of derivative security	-	40,712 Added 3.43%	1,144,646 Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$2,176,579 $128.2 p/Share	16,978 Reduced 1.51%	1,103,934 Common Stock
Mar 01 2025	BUY Exercise of conversion of derivative security	-	34,969 Added 3.03%	1,120,912 Common Stock
Jan 31 2025	SELL Payment of exercise price or tax liability	$1,934,591 $127.0 p/Share	15,233 Reduced 1.38%	1,085,943 Common Stock
Jan 31 2025	BUY Grant, award, or other acquisition	-	30,847 Added 2.72%	1,101,176 Common Stock
Dec 05 2024	SELL Open market or private sale	$4,362,192 $84.38 p/Share	51,697 Reduced 4.61%	1,070,329 Common Stock
Dec 05 2024	BUY Exercise of conversion of derivative security	$658,102 $12.73 p/Share	51,697 Added 4.4%	1,122,026 Common Stock
Dec 04 2024	SELL Open market or private sale	$4,376,310 $85.81 p/Share	51,000 Reduced 4.55%	1,070,329 Common Stock
Dec 04 2024	BUY Exercise of conversion of derivative security	$649,230 $12.73 p/Share	51,000 Added 4.35%	1,121,329 Common Stock
Aug 30 2024	SELL Open market or private sale	$2,511,939 $73.03 p/Share	34,396 Reduced 3.11%	1,070,329 Common Stock
Aug 30 2024	BUY Exercise of conversion of derivative security	$437,861 $12.73 p/Share	34,396 Added 3.02%	1,104,725 Common Stock
Aug 29 2024	SELL Open market or private sale	$2,593,751 $72.85 p/Share	35,604 Reduced 3.22%	1,070,329 Common Stock
Aug 29 2024	BUY Exercise of conversion of derivative security	$453,238 $12.73 p/Share	35,604 Added 3.12%	1,105,933 Common Stock
Aug 28 2024	SELL Open market or private sale	$2,394,220 $73.22 p/Share	32,699 Reduced 2.96%	1,070,329 Common Stock
Aug 28 2024	BUY Exercise of conversion of derivative security	$574,521 $17.57 p/Share	32,699 Added 2.88%	1,103,028 Common Stock
Aug 27 2024	SELL Open market or private sale	$2,982,972 $73.63 p/Share	40,513 Reduced 3.65%	1,070,329 Common Stock
Aug 27 2024	BUY Exercise of conversion of derivative security	$711,813 $17.57 p/Share	40,513 Added 3.52%	1,110,842 Common Stock
Aug 26 2024	SELL Open market or private sale	$1,694,162 $74.59 p/Share	22,713 Reduced 2.08%	1,070,329 Common Stock
Aug 26 2024	BUY Exercise of conversion of derivative security	$399,067 $17.57 p/Share	22,713 Added 2.04%	1,093,042 Common Stock
Aug 23 2024	SELL Open market or private sale	$2,135,512 $74.46 p/Share	28,680 Reduced 2.61%	1,070,329 Common Stock

Sharon Mates

Chairman and CEO

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITCI shares.

Notify only if

Value

Insider Trading

Get notified when an Intra Cellular Therapies, Inc. insider buys or sells ITCI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Intra-Cellular Therapies, Inc.

Track Activities on ITCI

Account